CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 12:00PM GMT
Release Date Price: R$26.08
Rivka Regina Goldwasser
Morgan Stanley, Research Division - MD

Welcome to day 2 of Morgan Stanley's Global Healthcare Conference. I'm Ricky Goldwasser, Morgan Stanley's health care services analyst. And it is my pleasure to introduce our first speakers for today, Larry Merlo, President and CEO of CVS Health; and Eva Boratto, CFO. Larry, Eva, welcome to our conference. Before we start, I just need to remind you all that for all important disclosures, you can go to the Morgan Stanley website.

And with that, Larry, 2019 is a big year for CVS. You're putting together this foundation for kind of the new enterprise. So maybe we can kick the conversation by you making some introductory remarks just to kind of like help frame the year and the conversation.

Larry J. Merlo
CVS Health Corporation - President, CEO & Director

Sure. Well, Ricky, thanks, and good morning, everyone. It's great to be here. Ricky, to your point, it's been about 9 months now since CVS and Aetna became one company. And we feel really good about how we're executing against our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot